We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SKIN market cap is 181.22M. The company's latest EPS is USD -0.8066 and P/E is -15.48.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 117.48M | 97.41M | 96.82M | 81.4M | 90.59M |
| Operating Income | -13.15M | -82.1M | -18.96M | -16.99M | -22.11M |
| Net Income | 5.39M | -78.57M | -4.65M | -679k | 202k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 260.09M | 365.88M | 397.99M |
| Operating Income | -1.21M | -36.64M | -24.28M | -130.92M |
| Net Income | -1.11M | -375.11M | 44.38M | -100.12M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 1.01B | 973.07M | 929.11M | 844.74M | 711.83M |
| Total Liabilities | 845.63M | 883.12M | 869.72M | 781.45M | 642.64M |
| Total Equity | 161.84M | 89.96M | 59.39M | 63.3M | 69.19M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 464M | 1.22B | 1.01B | 929.11M |
| Total Liabilities | 16.87M | 916.51M | 837.43M | 869.72M |
| Total Equity | 5M | 302.3M | 171.48M | 59.39M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | 8.96M | 26.92M | 21.75M | -16.85M | -10.65M |
| Investing | -24.9M | -29.34M | -31.51M | -1.8M | -3.84M |
| Financing | -3.74M | -6.09M | -37.45M | -58.62M | -157.37M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.09M | -28.36M | -106.6M | 21.75M |
| Investing | -460M | -37.73M | -18.87M | -31.51M |
| Financing | 464.36M | 959.04M | -205.24M | -37.45M |
| Market Cap | 181.22M |
| Price to Earnings Ratio | -15.48 |
| Price to Sales Ratio | 3.9 |
| Price to Cash Ratio | 2.96 |
| Price to Book Ratio | 26.1 |
| Dividend Yield | - |
| Shares Outstanding | 124.12M |
| Average Volume (1 week) | 645.58k |
| Average Volume (1 Month) | 573.44k |
| 52 Week Change | -52.90% |
| 52 Week High | 5.17 |
| 52 Week Low | 0.91 |
| Spread (Intraday) | 1.45 (52.35%) |
| Company Name | Beauth Health Company |
| Address |
1819 west avenue bay 2 miami beach, florida 33139 |
| Website | https:// |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
